Psorcon E Ointment

Name: Psorcon E Ointment

PSORCON® E Emollient Ointment (diflorasone diacetate ointment) 0.05%

Not For Ophthalmic Use

Psorcon E Ointment Description

Each gram of Psorcon E Emollient Ointment contains 0.5 mg diflorasone diacetate in an ointment base. Chemically, diflorasone diacetate is: 6α,9-difluoro-11β,17,21-trihydroxy-16β-methyl-pregna-1,4-diene-3,20-dione 17,21-diacetate. The structural formula is represented below:

Psorcon E Emollient Ointment contains diflorasone diacetate in an emollient, occlusive base consisting of polyoxypropylene 15-stearyl ether, stearic acid, lanolin alcohol and white petrolatum.

Indications and Usage for Psorcon E Ointment

Topical corticosteroids are indicated for relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.


Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects. (See PRECAUTIONS.)

How is Psorcon E Ointment Supplied

Psorcon E Emollient Ointment is available as follows:

15 gram tube NDC 0066-0275-17
30 gram tube NDC 0066-0275-31
60 gram tube NDC 0066-0275-60

Store at controlled room temperature, 20° to 25° C (68° to 77° F) [see USP].

Rx only

Manufactured for
Dermik Laboratories, Inc.
Berwyn, PA USA 19312
By Pharmacia & Upjohn Company
A Division of Pfizer Inc
Kalamazoo, MI, USA 49001

817 503 005
December 2001

diflorasone diacetate ointment
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0066-0275
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
diflorasone diacetate (diflorasone) diflorasone 0.5 mg  in 1 g
Inactive Ingredients
Ingredient Name Strength
polyoxypropylene 15-stearyl ether  
stearic acid  
lanolin alcohol  
white petrolatum  
# Item Code Package Description
1 NDC:0066-0275-17 15 g (15 GRAM) in 1 TUBE
2 NDC:0066-0275-31 30 g (30 GRAM) in 1 TUBE
3 NDC:0066-0275-60 60 g (60 GRAM) in 1 TUBE
Labeler - Dermik Laboratories, Inc.
Revised: 02/2006   Dermik Laboratories, Inc.